Home / Recalls / Cipla USA, Inc. / D-0043-2025

D-0043-2025 Class II Ongoing

Recalled by Cipla USA, Inc. — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
November 20, 2024
Initiation Date
October 23, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,875 boxes (cipla and exlan)

Product Description

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Distribution Pattern

USA nationwide.

Code Information

Lot # NB240316, Exp 12/31/25

Other recalls by Cipla USA, Inc.

  • D-0381-2026 Class III — Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactur (February 18, 2026)
  • D-0382-2026 Class III — Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactur (February 18, 2026)
  • D-0290-2026 Class II — Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep sub (January 2, 2026)
  • D-0291-2026 Class III — Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT (December 22, 2025)
  • D-0225-2026 Class II — Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufac (November 14, 2025)
  • D-0226-2026 Class II — Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufac (November 14, 2025)
  • D-0224-2026 Class II — Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufac (November 14, 2025)
  • D-0218-2026 Class II — Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack car (October 24, 2025)
  • D-0217-2026 Class II — Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack car (October 24, 2025)
  • D-0593-2025 Class III — Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONT (July 24, 2025)